Establishment Labs Holdings Inc. (NASDAQ:ESTA) Stock Has Consensus Price Target of $95.00 According to Analysts

Key Points

• Analyst sentiment is broadly positive: Nine of ten analysts rate Establishment Labs a buy, while one rates it a sell; the average 12-month price target is $95.
• Latest results were mixed: Quarterly revenue was $71.99 million, above estimates and up 33.8% year over year, but EPS was a loss of $0.35, worse than the expected $0.26 loss.
• Institutional investors and hedge funds own 72.91% of the company’s shares.

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) have been given an average rating of "Moderate Buy" by the ten ratings firms that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating and nine have issued a buy rating on the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $95.00.

A number of research analysts have weighed in on ESTA shares. TD Cowen decreased their price objective on Establishment Labs from $117.00 to $95.00 and set a "buy" rating on the stock in a report on Monday, October 26th. Needham & Company LLC increased their target price on shares of Establishment Labs from $86.00 to $95.00 and gave the company a "buy" rating in a research report on Thursday, August 6th. JPMorgan Chase & Co. raised their price target on shares of Establishment Labs from $84.00 to $95.00 and gave the stock an "overweight" rating in a research note on Friday, August 7th. BTIG Research lowered their price target on shares of Establishment Labs from $103.00 to $93.00 and set a "buy" rating on the stock in a research report on Thursday, October 29th. Finally, Mizuho upped their price objective on shares of Establishment Labs from $100.00 to $105.00 and gave the company an "outperform" rating in a research note on Wednesday, July 15th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ESTA. Integrated Wealth Concepts LLC acquired a new stake in shares of Establishment Labs in the second quarter valued at approximately $32,000. KBC Group NV acquired a new position in Establishment Labs during the first quarter worth $28,000. Northwestern Mutual Wealth Management Co. acquired a new position in Establishment Labs during the second quarter worth $43,000. Sterling Capital Management LLC grew its holdings in Establishment Labs by 849.5% in the 3rd quarter. Sterling Capital Management LLC now owns 902 shares of the company's stock valued at $58,000 after buying an additional 807 shares in the last quarter. Finally, State of Wyoming purchased a new stake in Establishment Labs in the 2nd quarter valued at $87,000. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Establishment Labs Price Performance

NASDAQ:ESTA opened at $68.52 on Tuesday. The stock has a 50 day moving average of $66.22 and a two-hundred day moving average of $72.30. Establishment Labs has a 12 month low of $53.16 and a 12 month high of $97.59. The firm has a market cap of $2.04 billion, a P/E ratio of -53.53 and a beta of 1.03. The company has a current ratio of 3.84, a quick ratio of 2.52 and a debt-to-equity ratio of 12.11.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its quarterly earnings results on Friday, October 30th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.09). The firm had revenue of $71.99 million during the quarter, compared to analyst estimates of $66.81 million. Establishment Labs had a negative return on equity of 185.60% and a negative net margin of 14.56%. The business's revenue was up 33.8% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.38) earnings per share. On average, analysts expect that Establishment Labs will post -1.18 earnings per share for the current fiscal year.

About Establishment Labs

Establishment Labs Holdings Inc is a medical technology company focused on breast health and aesthetics. Founded in 2004 by Juan José Chacón-Quirós, the Costa Rica-based company develops and manufactures products for breast augmentation and reconstruction.

Its product portfolio includes Motiva breast implants, offered in different shapes and designs, as well as related technologies and products for plastic and reconstructive surgery. The company also develops solutions intended to support surgical procedures and patient care.

Establishment Labs serves healthcare providers and patients in international markets, with products distributed across numerous countries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.